- Home
- MRK vs APP Comparison
MRK vs APP Comparison
Compare MRK & APP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRK
- APP
- Stock Information
- Founded
- MRK 2000
- APP 2012
- Country
- MRK United States
- APP United States
- Employees
- MRK N/A
- APP N/A
- Industry
- MRK Biotechnology: Pharmaceutical Preparations
- APP EDP Services
- Sector
- MRK Health Care
- APP Technology
- Exchange
- MRK Nasdaq
- APP Nasdaq
- Market Cap
- MRK 218.8B
- APP 203.1B
- IPO Year
- MRK N/A
- APP 2021
- Fundamental
- Price
- MRK $87.40
- APP $620.60
- Analyst Decision
- MRK Buy
- APP Buy
- Analyst Count
- MRK 15
- APP 21
- Target Price
- MRK $105.14
- APP $603.15
- AVG Volume (30 Days)
- MRK 12.0M
- APP 6.0M
- Earning Date
- MRK 10-30-2025
- APP 11-05-2025
- Dividend Yield
- MRK 3.70%
- APP N/A
- EPS Growth
- MRK 20.41
- APP 198.85
- EPS
- MRK 6.49
- APP 7.03
- Revenue
- MRK $63,616,000,000.00
- APP $5,737,591,000.00
- Revenue This Year
- MRK $1.76
- APP $20.49
- Revenue Next Year
- MRK $5.11
- APP $33.54
- P/E Ratio
- MRK $13.49
- APP $88.19
- Revenue Growth
- MRK 1.82
- APP 78.91
- 52 Week Low
- MRK $73.31
- APP $158.08
- 52 Week High
- MRK $106.62
- APP $745.61
- Technical
- Relative Strength Index (RSI)
- MRK 58.17
- APP 55.02
- Support Level
- MRK $86.91
- APP $547.13
- Resistance Level
- MRK $88.79
- APP $616.28
- Average True Range (ATR)
- MRK 1.54
- APP 29.48
- MACD
- MRK 0.11
- APP -6.39
- Stochastic Oscillator
- MRK 73.34
- APP 68.17
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About APP Applovin Corporation
AppLovin is a vertically integrated advertising technology company that acts as a demand-side platform for advertisers, a supply-side platform for publishers, and an exchange facilitating transactions between the two. About 80% of AppLovin's revenue comes from the DSP, AppDiscovery, while the remainder comes from the SSP, Max. AppLovin's primary tool for future growth is AXON 2, which is an ad optimizer operating within the DSP that allows advertisers to place ads according to specified return thresholds.